Addition of CYTOMEL therapy in individuals with diabetes mellitus may well worsen glycemic control and result in amplified antidiabetic agent or insulin prerequisites. Cautiously monitor glycemic Command, specially when CYTOMEL is started off, adjusted, or discontinued [see WARNINGS AND PRECAUTIONS]. For patients with serum TSH previously mentioned the normal trimester-particular http://www.t3tiromel.com